Patients with JIA-associated uveitis who discontinued adalimumab had higher recurrence rates than those who continued the ...

The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...

PHILADELPHIA- After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient ...

Researchers used an AI-driven approach to identify adalimumab as a potential life-saving treatment for idiopathic ...

UBS forecasts that Sandoz will likely achieve the lower end of its 24-26% core EBITDA margin target by 2028. To reach the ...

Teaser: Off-label systemic agents may treat inflammatory autoimmune vulvar diseases such as lichen sclerosus and lichen ...

While you wait for the groundhog to make his determination this weekend, take some time to buff up your knowledge of ...

Celltrions Vegzelma becomes Europes top prescribed anticancer drug in two years Celltrions cancer treatment Vegzelma achieves impressive market dominance in Europe within two years ...